EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry

Shunsuke Kitani iD, Yasumi Igarashi, Etsuo Tsuchikane, Shigeru Nakamura, Ryoji Koshida, Maoto Habara iD, Michinao Tan iD, Kenichiro Shimoji iD, Tomofumi Takaya iD, Mikihiro Kijima

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31283 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Shunsuke Kitani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sapporo Kosei General Hospital, Hokkaido, Japan. Hauptthemen laut MEDLINE: Coated Materials, Biocompatible, Coronary Artery Disease, Atherectomy, Coronary, Angioplasty, Balloon, Coronary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long‐term efficacy of drug‐coated balloon (DCB) angioplasty for large bifurcation lesions, particularly those involving the left main trunk (LMT), remains unclear.

Aims

This study aimed to evaluate the long‐term outcomes of directional coronary atherectomy followed by DCB (DCA/DCB) for large bifurcation lesions.

Methods

This retrospective multicenter study analyzed 129 cases from the DCA/DCB registry, with 80.4% involving LMT bifurcation lesions. Building on previously reported 12‐month outcomes, this study assessed long‐term results. The primary endpoint was clinically driven (CD) target lesion revascularization (TLR) at 36 months. Secondary endpoints included CD target vessel revascularization (TVR); CD target vessel failure (TVF); and adverse events, such as all‐cause mortality, cardiac death, target vessel acute myocardial infarction (AMI), and the need for coronary artery bypass grafting (CABG), at 24 and 36 months.

Results

The mean follow‐up was 53.4 ± 23.9 months. The CD‐TLR rate was 5.0% at 24 months, and the primary endpoint was 5.9% at 36 months. CD‐TVR rates were 14.0% at 24 months and 15.0% at 36 months, while CD‐TVF rates were 14.9% at 24 months and 16.7% at 36 months. Adverse events included all‐cause mortality rates of 0.8% at 24 months and 1.8% at 36 months, and cardiac death rates of 0.8% at both 24 and 36 months. No target vessel AMI or CABG procedures were reported.

Conclusion

The consistently low CD‐TLR rate at 36 months supports the efficacy of the DCA/DCB strategy for large bifurcation lesions, including LMT, indicating its sustained effectiveness. These findings highlight the viability of this treatment approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coated Materials, BiocompatibleCoronary Artery DiseaseAtherectomy, CoronaryAngioplasty, Balloon, CoronaryCardiac CathetersCardiovascular AgentsHumansRegistriesMaleRetrospective StudiesFemaleTreatment OutcomeTime FactorsAgedMiddle AgedRisk FactorsEquipment Design

Stichwörter der Autor:innen

coronary bifurcation lesionsdirectional coronary atherectomydrug‐coated balloonleft main trunkpercutaneous coronary intervention

Substanzen

Coated Materials, BiocompatibleCardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, Sapporo Kosei General Hospital, Hokkaido, Japan.
  • Department of Cardiovascular Medicine, Toyohashi Heart Center, Aichi, Japan.
  • Cardiovascular Center, Kyoto Katsura Hospital, Kyoto, Japan.
  • Cardiology and Vascular Medicine, Hoshi General Hospital, Fukushima, Japan.
  • Cardiovascular Center, Tokeidai Memorial Hospital, Hokkaido, Japan.
  • Department of Cardiology, Saiseikai Utsunomiya Hospital, Tochigi, Japan.

ORCID-Profile: Shunsuke Kitani, Maoto Habara, Michinao Tan, Kenichiro Shimoji, Tomofumi Takaya

Zitieren

APA

Kitani, S., Igarashi, Y., Tsuchikane, E., Nakamura, S., Koshida, R., Habara, M., Tan, M., Shimoji, K., Takaya, T., & Kijima, M. (2025). Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31283

Vancouver

Kitani S, Igarashi Y, Tsuchikane E, Nakamura S, Koshida R, Habara M, et al. Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31283

BibTeX
@article{Kitani2025,
  author = {Kitani, Shunsuke and Igarashi, Yasumi and Tsuchikane, Etsuo and Nakamura, Shigeru and Koshida, Ryoji and Habara, Maoto and Tan, Michinao and Shimoji, Kenichiro and Takaya, Tomofumi and Kijima, Mikihiro},
  title = {Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31283}
}
Kostenlos starten →